Get Patient Forms

costs $3,300 an injection, so a full course of eight injections would cost about $26,000, in addition to a doctor's fee. Doctors already use less expensive drugs off-label to treat Peyronies, including injections of a generic blood pressure drug.

Actual patient ~24 72 hours after ® injection. Actor portrayal. WHAT IS ®? ® is a prescription medicine used to treat adults with Dupuytren's contracture when a cord can be felt.

® for the treatment of Peyronie's disease is only available through a restricted program called the ® Risk Evaluation and Mitigation Strategy (REMS) Program. For more information about the ® REMS Program, go to www.XIAFLEXREMS.com or call 1 877 313 1235.

Pain. Although is not uncomfortable to receive, some patients have significant pain for up to 48 hours after the injection, with rare patients having discomfort beyond this period. is more painful to receive, likely due to the volume of fluid, but is not significantly painful thereafter.

Results: Success was achieved in 36 of 47 treated joints (76.6%) after a single injection. There were 2 recurrences in 32 joints at 30-day follow-up (6.2%) and no recurrences in 17 joints available at 6-month follow-up.

Pain. Although is not uncomfortable to receive, some patients have significant pain for up to 48 hours after the injection, with rare patients having discomfort beyond this period. is more painful to receive, likely due to the volume of fluid, but is not significantly painful thereafter.

For more information, see helpful tips and reminders or call Endo Advantage at 1-877- (1-877-942-3539), Monday through Friday, from 9:00 AM to 8:00 PM ET. NOTE: Insurers may require you to use a specific acquisition method. NOTE: This form is only needed for "buy-and-bill" reimbursement.

For Open Drug Formularies, ® will be fully covered.

The dose of ® is 0.58 mg per injection into a palpable cord with a contracture of a metacarpophalangeal (MP) joint or a proximal interphalangeal (PIP) joint. Each vial of ® and sterile diluent should only be used for a single injection.

g. clostridium histolyticum also is approved for the treatment of moderate to severe cellulite in the buttock. This is considered a cosmetic use and therefore not covered under the medical benefit.